Home | Coriolis Pharma

Coriolis Pharma Formulating innovation

For us innovation is progress achieved by collaboration. We generate innovation by combining technologies, knowledge and experience.

Formulating for us means to find the right solution.

About us

Coriolis is a globally operating service provider and one of the world leaders in formulation research and development of (bio)pharmaceutical drugs and vaccines.

As a family-owned and independent company with an interdisciplinary team of highly skilled scientists and an expert scientific advisory board, we provide cutting-edge services and tailor-made solutions for our customers.

Formulation Development

“It is a medicine, not a molecule, that we are giving to the patient” Marc B. Brown, 2005.

Coriolis is the expert in developing liquid and lyophilized formulations for a large variety of different (bio)pharmaceutical molecules.

Find out how we can support your drug development...

Analytical Services

A highly diverse analytical portfolio entirely performed in-house: This is Coriolis.

With the latest in technology and highly experienced scientists, we are a trendsetter in the field.

Get to know our services...

About us

Independent, reliable and always on the cutting edge of science. Coriolis is the leading service provider for formulation research and development of (bio)pharmaceutical drugs and vaccines.

Get to know us...

Latest news

2020/10/28

Coriolis participates at Festival of Biologics

Listen to the talk by Coriolis CTO Dr. Tim Menzen and meet us at our exhibition booth.

2020/10/26

Webinar: Nanoparticulate Impurities in Excipients - A Threat to Protein Stability

Merck Life Science hosts Webinar with Coriolis Scientists

2020/10/20

Coriolis Expert Gives Talk About the Application of Analytical Ultracentrifugation for Biopharmaceuticals

Dr. Klaus Richter speaks at the 11th Biologics Formulation Development and Drug Delivery Event

2020/10/14

Coriolis participates at the PDA Visual Inspection Forum

Visit our virtual exhibition booth and meet Dr. Jörg Müller online.

2020/07/20

Study by Coriolis proposes new degradation mechanism for polysorbate

Micelles may function as nanoscale reaction vessels for polysorbate oxidation

2020/06/29

Coriolis CSO gives talk about analytical techniques for polysorbate characterization

Listen to Dr. Andrea Hawe's talk at Thermo Scientific's virtual Biopharmaceutical Symposium

2020/06/03

Modulating Scanning Fluorimetry (MSF): Unlocking a thermal protein-stability parameter for early drug development

At what temperature does protein unfolding become irreversible? - This new method only needs a few µl of sample to give you the answer.

2020/05/29

Coriolis participates at the BioProcess International Conference

Visit our virtual booth and meet Dr. Matthias Lucke and Dr. Jörg Müller online.

2020/05/12

Coriolis participates at PDA Europe's virtual ATMP conference

Visit our virtual booth and listen to the talk by our CTO

2020/04/30

Coriolis participates in Covid-19 Virtual Partnering Event

Meet Dr. Stefan Heindl at the digital event from 4. - 6. May

View all

Latest publications

Advanced Therapy Medicinal Products: What's in a Name?

Jiskoot W.

Micelle driven oxidation mechanism and novel oxidation markers for different grades of polysorbate 20 and 80

Kranz W, Wuchner K, Corradini E, Menzen T, Hawe A.

Particulate impurities in cell-based medicinal products traced by flow imaging microscopy combined with deep learning for image analysis

Grabarek AD, Senel E, Menzen T, Hoodendoorn KH, Pike-Overzet K, Hawe A, Jiskoot W.

Heat Flux Sensor to Create a Design Space for Freeze-Drying Development

Marco Carfagna, Monica Rosa, Matthias Lucke, Andrea Hawe, Wolfgang Frieß

Modulated Scanning Fluorimetry Can Quickly Assess Thermal Protein Unfolding Reversibility in Microvolume Samples

Hristo L Svilenov, Tim Menzen, Klaus Richter, Gerhard Winter

Exploring Chemical Space for New Substances to Stabilize a Therapeutic Monoclonal Antibody.

Tosstorff A, Menzen T, Winter G.

Taking subvisible particle quantitation to the limit: Uncertainties and statistical challenges with ophthalmic products for intravitreal injection.

Gühlke M, Hecht J, Böhrer A, Hawe A, Nikels F, Garidel P, Menzen T.

Phase-Appropriate Application of Analytical Methods to Monitor Subvisible Particles Across the Biotherapeutic Drug Product Life Cycle.

Mathaes R, Narhi L, Hawe A, Matter A, Bechtold-Peters K, Kenrick S, Kar S, Laskina O, Carpenter J, Cavicchi R, Koepf E, Lewis EN, De Silva R, Ripple D.

Factors Influencing Polysorbate's Sensitivity Against Enzymatic Hydrolysis and Oxidative Degradation.

Kranz W, Wuchner K, Corradini E, Berger M, Hawe A.

Intrinsic Differential Scanning Fluorimetry for Fast and Easy Identification of AAV Serotypes.

Rieser R, Penaud-Budloo M, Bouzelha M, Rossi A, Menzen T, Biel M, Büning H, Ayuso E, Winter G, Michalakis S.

View all